Ouranidis, A.; Vavilis, T.; Mandala, E.; Davidopoulou, C.; Stamoula, E.; Markopoulou, C.K.; Karagianni, A.; Kachrimanis, K.
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 2022, 10, 50.
https://doi.org/10.3390/biomedicines10010050
AMA Style
Ouranidis A, Vavilis T, Mandala E, Davidopoulou C, Stamoula E, Markopoulou CK, Karagianni A, Kachrimanis K.
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines. 2022; 10(1):50.
https://doi.org/10.3390/biomedicines10010050
Chicago/Turabian Style
Ouranidis, Andreas, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Eleni Stamoula, Catherine K. Markopoulou, Anna Karagianni, and Kyriakos Kachrimanis.
2022. "mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles" Biomedicines 10, no. 1: 50.
https://doi.org/10.3390/biomedicines10010050
APA Style
Ouranidis, A., Vavilis, T., Mandala, E., Davidopoulou, C., Stamoula, E., Markopoulou, C. K., Karagianni, A., & Kachrimanis, K.
(2022). mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines, 10(1), 50.
https://doi.org/10.3390/biomedicines10010050
